Trial Profile
A Pharmacokinetic, Pharmacodynamic and Safety Study of Single and Multiple Doses of Rabeprazole in Pediatric Subjects With GERD 1 to 11 Months Old, Inclusive
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Dec 2021
Price :
$35
*
At a glance
- Drugs Rabeprazole (Primary)
- Indications Gastro-oesophageal reflux
- Focus Adverse reactions; Pharmacodynamics; Pharmacogenomic; Pharmacokinetics
- Sponsors Janssen Research & Development; Janssen-Cilag
- 21 Jul 2019 This trial has been completed in United Kingdom, according to European Clinical Trials Database.
- 01 May 2012 Actual patient number is 51 according to ClinicalTrials.gov.
- 01 May 2012 Actual end date (Feb 2012) added as reported by ClinicalTrials.gov.